Wockhardt Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/05/2026 ,inter alia, to consider and approve We wish to inform you that a meeting ....
WOCKPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Wockhardt Ltd has scheduled a Board meeting on 4th May 2026 to consider and approve the Audited Financial Results for Q4 and FY ended 31st March 2026 (Standalone & Consolidated). Additionally, the Board will consider raising funds through various instruments including equity shares, GDRs, ADRs, FCCBs, FCDs, NCDs and other convertible securities via public/private offerings, QIP or preferential allotment. The fundraising is subject to shareholder approval at the AGM. The trading window has been closed since 1st April 2026 and will remain closed till 48 hours after results declaration. This is a routine regulatory intimation under SEBI LODR Regulations.
The filing indicates upcoming Q4/FY2026 results which could impact the stock. The fund-raising proposal suggests the company may be looking to strengthen its balance sheet or fund growth plans, which could be dilutive for existing shareholders if approved.